ShareQ3 of 2018 was released May 18th I believe, for the 3 to 9 months ended March 31 2018.
On January 28th it was announced that total licensed space at 120,000 sqft, and capacity of 17,500 kg. Then stated the facility remains on track for a total construction completion of all flowering rooms rooms by the end of March.
We're near the end of February and still haven't heard any updates, or approval of the supposedly completed rooms awaiting inspection, international news, Kush etc etc.
The company is still faced with the 100 million bought deal.
I believe Q2 was a disappointment for many investors, and in my opinion it now looks like Q3 might be average, therefore it is understandable many investors purchase low and sell high until or if the company make the market react.
Penny stock is a risky investment, and at the moment there is no hype regarding this company. Not sure what their strategy is, and every one is entitled to their opinion and investing strategies, but at the moment I prefer being out looking in, and if it gains traction, then purchase.
IMHO